Table 2 Prevalence and co-occurrence of urogenital species among 28 Trichomonas vaginalis-positive and 51 T. vaginalis-negative women
Species | Overall prevalence (N = 79) (95% CI) | %TV+/%TV- | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|
COR (95% CI) | P-value | AOR (95% CI) | P-value | |||
Candida albicans | 24.1 (15.1–35.0) | 32.1/19.6 | 1.9 (0.7–5.6) | 0.216 | – | – |
Chlamydia trachomatis | 13.9 (7.2–23.5) | 21.4/9.8 | 2.5 (0.7–9.1) | 0.163 | – | – |
Escherichia coli | 27.8 (18.3–39.1) | 35.7/23.5 | 1.8 (0.7–4.9) | 0.251 | – | – |
Mycoplasma genitalium | 6.3(2.1–14.2) | 17.9/0.0 | 5.0 (0.3–94.3)* | 0.002 | ||
Ca. Mycoplasma girerdii | 7.6 (2.8–15.8) | 21.4/0.0 | 4.3 (0.2–78.4)* | 0.001 | ||
Mycoplasma hominis | 41.8 (30.8–53.4) | 71.4/25.5 | 7.3 (2.6–20.5) | < 0.001 | 6.8 (2.3–19.8) | < 0.001 |
Streptococcus agalactiae | 11.4 (5.3–20.5) | 7.1/13.7 | 0.5 (0.1–2.5) | 0.386 | – | – |
Ureaplasma parvum | 74.7 (63.6–83.8) | 78.9/72.6 | 1.4 (0.5–4.1) | 0.557 | – | – |
Ureaplasma urealyticum | 48.1 (36.7–59.6) | 60.7/41.2 | 2.2 (0.9–5.7) | 0.099 | 1.3 (0.4–3.8) | 0.624 |
Cytomegalovirus | 1.3 (0–6.9) | 0.0/2.0 | 1.7 (6.6–4210.4)* | 0.456 | ||
HIV | 3.8 (0.7–10.7) | 10.7/0.0 | 7.9 (0.4–158.5)* | 0.017 | ||
HSV 1, HSV 2 | 2.5 (0.3–8.8) | 7.1/0.0 | 11.1 (0.5–238.6)* | 0.053 | ||
Bacterial vaginosis | 5.1 (1.4–12.5) | 14.3/0.0 | 6.2 (0.3–118.4)* | 0.006 | ||